Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

US Patent 10610530 · Granted Apr 7, 2020

Estimated economic value: $68,133,000

Assignee

Inventors

View full patent text on Google Patents →